Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-07-25
2024-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-management Program in Patients With COPD
NCT07068269
Circuit and Resistance Training in COPD
NCT06601764
Comparison of Jacobson Relaxation Technique and Pranayama Technique in Patients With COPD
NCT06463288
Comparative Effects of IMT Vs EMT Along With AIT in COPD Patients
NCT06308302
Effects of Breathing Exercises With and Without Inspiratory Muscle Training in COPD Patients
NCT06555445
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Spirometry assesses the amount and speed of air that can be inhaled and exhaled. Key measurements include Forced Vital Capacity (FVC). The maximum volume of air forcefully exhaled after a full inhalation. Forced Expiratory Volume in 1 second (FEV1): The volume of air exhaled in the first second of the FVC test, indicates how quickly the lungs can be emptied.
The modified Borg dyspnea score is a variation of the CR10 scale, with a range from 0 to 10, where 0 signifies the absence of breathlessness and 10 indicates the highest level of breathlessness. Participants assess their dyspnea after the 6-minute walk distance (6MWD) test, capturing the peak intensity of breathlessness experienced throughout the entire walking test. This scoring system provides a subjective measure of the individual's maximal perceived dyspnea during physical activity.
The SATED scale includes specific quantitative criteria for four of the five sleep-related dimensions that have been reliably linked to health outcomes. It evaluates five important aspects of sleep. These include the following dimensions: sleep satisfaction, sleep efficiency, sleep duration, timing of sleep, and alertness during waking hours.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Senobi exercises
* Group A had undergone Senobi exercises training, scheduled three times weekly over 8 weeks, for individuals with COPD the duration and time interval time for Senobi exercises can vary depending on their overall health, fitness level, and tolerance.
* The session began with the comfortable sitting of participants with slow inhalation, filling the lungs for a count of 4-5 seconds and holding the breath for 2-3 seconds.
* In the second step exhale slowly through the mouth, emptying the lungs for a count of 4-5 seconds, and hold the breath for 2-3 seconds.
* The session started with a shorter session (3-5 minutes) and increased gradually as participants built up endurance with a breathing rate of 4-6 breaths per minute.
* The cycle of Senobi exercises was repeated for 5-10 minutes and 2-3 times a day.
Senobi exercises
Senobi exercise began with the comfortable sitting of participants with slow inhalation, filling the lungs for a count of 4-5 seconds and holding the breath for 2-3 seconds.
Jacobsons Muscular relaxation exercises
* Group B engaged in a Jacobsons Muscular relaxation exercises plan, following the same frequency and duration as the Senobi exercise program-three sessions per week for 8 weeks.
* The session started by tensing the muscles in the toes and then moving up the body tensing and relaxing each muscle group in turn (feet and toes, calves, thighs, hips, lower back, upper back, shoulders, arms, hands, neck, and head) and hold it for 5-7 seconds and released it for 5-7 seconds.
* Repeat the cycle 2-3 times per day with deep breaths between each cycle.
* The session started with a shorter session (3-5 minutes) and increased gradually as participants built up endurance with a breathing rate of 4-6 breaths per minute.
Jacobsons Muscular relaxation exercises
Jacobsons Muscular relaxation exercises started by tensing the muscles in the toes and then moving up the body tensing and relaxing each muscle group in turn (feet and toes, calves, thighs, hips, lower back, upper back, shoulders, arms, hands, neck, and head) and hold it for 5-7 seconds and released it for 5-7 seconds.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Senobi exercises
Senobi exercise began with the comfortable sitting of participants with slow inhalation, filling the lungs for a count of 4-5 seconds and holding the breath for 2-3 seconds.
Jacobsons Muscular relaxation exercises
Jacobsons Muscular relaxation exercises started by tensing the muscles in the toes and then moving up the body tensing and relaxing each muscle group in turn (feet and toes, calves, thighs, hips, lower back, upper back, shoulders, arms, hands, neck, and head) and hold it for 5-7 seconds and released it for 5-7 seconds.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 35-50 years
* Diagnosed COPD patients of stage 2-3 according to gold criteria (moderate)
Exclusion Criteria
* History of fractures (68)
* History of other pulmonary complications
35 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tasneem Shehzadi, Mphil
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Lahore Teaching Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/RCR & AHS/23/0374
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.